Study #PA11-0852
Molecular and Germline testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study performs standardized testing of tumor tissue samples to learn which genes are mutated (have changed) in order to provide personalized cancer therapy options to cancer patients at MD Anderson. This may help doctors use testing information on tumors to identify clinical trials that may be most relevant to patients. Researchers may also use the information learned from this study to develop a database of the different kinds of mutations in cancer-related genes.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Glioma;Hematopoietic and Lymphoid Cell Neoplasm;Malignant Solid Neoplasm;Melanoma;Sarcoma
Study phase:
Physician name:
Funda Meric-Bernstam
Department:
Investigational Cancer Therapeutics
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.